Cargando…

What are the information priorities for cancer patients involved in treatment decisions? An experienced surrogate study in Hodgkin's disease.

A total of 165 adult patients with Hodgkin's disease (HD) were questioned following treatment to examine their perceptions of actual and desired involvement and provision of information in the treatment decision-making process. Irrespective of the degree to which patients felt they had been inv...

Descripción completa

Detalles Bibliográficos
Autores principales: Turner, S., Maher, E. J., Young, T., Young, J., Vaughan Hudson, G.
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 1996
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2074302/
https://www.ncbi.nlm.nih.gov/pubmed/8546910
_version_ 1782137938552815616
author Turner, S.
Maher, E. J.
Young, T.
Young, J.
Vaughan Hudson, G.
author_facet Turner, S.
Maher, E. J.
Young, T.
Young, J.
Vaughan Hudson, G.
author_sort Turner, S.
collection PubMed
description A total of 165 adult patients with Hodgkin's disease (HD) were questioned following treatment to examine their perceptions of actual and desired involvement and provision of information in the treatment decision-making process. Irrespective of the degree to which patients felt they had been involved in the decision-making process and of the outcome of their particular treatment, patients who felt satisfied with the adequacy of information given were significantly more likely to feel happy with their level of participation in the overall process of decision-making (P < 0.001). As part of a strategy investigating patient priorities, patients were asked to rank a series of possible acute and late treatment-related morbidities. Counter-intuitively, the majority of long-term survivors felt early short-term side-effects were more, or equally, as important as late morbidity with respect to influencing choice of therapy. Unpredictable importance was placed by patients on side-effects such as weight gain and fatigue in relation to other complications such as infertility and risk of relapse. Patients do not necessarily share doctors' priorities in decision-making or place the same emphasis on different types of morbidity. Experienced surrogates may assist us in understanding patients' perspectives and priorities.
format Text
id pubmed-2074302
institution National Center for Biotechnology Information
language English
publishDate 1996
publisher Nature Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-20743022009-09-10 What are the information priorities for cancer patients involved in treatment decisions? An experienced surrogate study in Hodgkin's disease. Turner, S. Maher, E. J. Young, T. Young, J. Vaughan Hudson, G. Br J Cancer Research Article A total of 165 adult patients with Hodgkin's disease (HD) were questioned following treatment to examine their perceptions of actual and desired involvement and provision of information in the treatment decision-making process. Irrespective of the degree to which patients felt they had been involved in the decision-making process and of the outcome of their particular treatment, patients who felt satisfied with the adequacy of information given were significantly more likely to feel happy with their level of participation in the overall process of decision-making (P < 0.001). As part of a strategy investigating patient priorities, patients were asked to rank a series of possible acute and late treatment-related morbidities. Counter-intuitively, the majority of long-term survivors felt early short-term side-effects were more, or equally, as important as late morbidity with respect to influencing choice of therapy. Unpredictable importance was placed by patients on side-effects such as weight gain and fatigue in relation to other complications such as infertility and risk of relapse. Patients do not necessarily share doctors' priorities in decision-making or place the same emphasis on different types of morbidity. Experienced surrogates may assist us in understanding patients' perspectives and priorities. Nature Publishing Group 1996-01 /pmc/articles/PMC2074302/ /pubmed/8546910 Text en https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/.
spellingShingle Research Article
Turner, S.
Maher, E. J.
Young, T.
Young, J.
Vaughan Hudson, G.
What are the information priorities for cancer patients involved in treatment decisions? An experienced surrogate study in Hodgkin's disease.
title What are the information priorities for cancer patients involved in treatment decisions? An experienced surrogate study in Hodgkin's disease.
title_full What are the information priorities for cancer patients involved in treatment decisions? An experienced surrogate study in Hodgkin's disease.
title_fullStr What are the information priorities for cancer patients involved in treatment decisions? An experienced surrogate study in Hodgkin's disease.
title_full_unstemmed What are the information priorities for cancer patients involved in treatment decisions? An experienced surrogate study in Hodgkin's disease.
title_short What are the information priorities for cancer patients involved in treatment decisions? An experienced surrogate study in Hodgkin's disease.
title_sort what are the information priorities for cancer patients involved in treatment decisions? an experienced surrogate study in hodgkin's disease.
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2074302/
https://www.ncbi.nlm.nih.gov/pubmed/8546910
work_keys_str_mv AT turners whataretheinformationprioritiesforcancerpatientsinvolvedintreatmentdecisionsanexperiencedsurrogatestudyinhodgkinsdisease
AT maherej whataretheinformationprioritiesforcancerpatientsinvolvedintreatmentdecisionsanexperiencedsurrogatestudyinhodgkinsdisease
AT youngt whataretheinformationprioritiesforcancerpatientsinvolvedintreatmentdecisionsanexperiencedsurrogatestudyinhodgkinsdisease
AT youngj whataretheinformationprioritiesforcancerpatientsinvolvedintreatmentdecisionsanexperiencedsurrogatestudyinhodgkinsdisease
AT vaughanhudsong whataretheinformationprioritiesforcancerpatientsinvolvedintreatmentdecisionsanexperiencedsurrogatestudyinhodgkinsdisease